跳至主要内容
临床试验/JPRN-UMIN000042905
JPRN-UMIN000042905招募中3 期

Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial - Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 330 人开始时间: 2021年1月5日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)History of synchronous or metachronous (within 3 years) malignancies (2)Active infection requiring systemic therapy (3)Fever with a body temperature higher than 38.0 degrees Celsius at the time of registration (4)Pregnant, possibly pregnant, within 28 days of delivery, breastfeeding females, or males expecting to father a child (5)Psychiatric illnesses or symptoms affecting the daily lives (6)Systemic treatment with steroids or immunosuppressive agents (7)Unstable angina(diagnosis or worsening of chest pain within 3 weeks) or history of myocardial infarction within 6 months prior to the registration

研究者

发起方
Japan Clinical Oncology Group (JCOG)

相似试验